Cardiovascular, Renal & Metabolic Diseases Market Growth
The cardiovascular, renal & metabolic diseases market size was $298.73 billion in 2024, up from $286.12 billion in 2023.
It is projected to grow to $451.87 billion by 2033, with a compound annual growth rate (CAGR) of 4.8% from 2025 to 2033.
The sizable market reflects the convergence of major chronic disease segments - cardiovascular diseases, renal diseases, and metabolic disorders.
- Market size in 2024: $298.73 billion
- Market size in 2023: $286.12 billion
- Projected market size in 2033: $451.87 billion
- CAGR from 2025 to 2033: 4.8%
Author's summary: Market to reach $451.87 billion by 2033.